Used as an intermediate in the synthesis of tyrosine kinase inhibitors, particularly in the development of anticancer agents. It plays a key role in targeting epidermal growth factor receptor (EGFR) pathways, which are involved in tumor cell proliferation and survival. Its structure supports high selectivity and potency in blocking abnormal signaling in cancer cells, making it valuable in pharmaceutical research for lung, breast, and other solid tumors. Also utilized in structure-activity relationship (SAR) studies to optimize drug candidates for improved efficacy and reduced resistance.